147 related articles for article (PubMed ID: 19065141)
1. A case of prolonged disease-free survival in a patient with choroidal metastasis from breast cancer.
Jang RW; Doherty M; Hopkins JJ; Warner E
Nat Clin Pract Oncol; 2009 Feb; 6(2):118-21. PubMed ID: 19065141
[TBL] [Abstract][Full Text] [Related]
2. Late distant recurrence of breast carcinoma and metastasis to the main bronchus and choroid: A case report.
Luo Z; Cai Q; Zhao Y; Wang X; Fu S; Zhai L
Medicine (Baltimore); 2018 May; 97(20):e10754. PubMed ID: 29768356
[TBL] [Abstract][Full Text] [Related]
3. Regression of choroidal metastasis from breast carcinoma following Letrozole therapy.
Venkatesh P; Garg S
Clin Exp Ophthalmol; 2007 Jul; 35(5):492-4. PubMed ID: 17651258
[TBL] [Abstract][Full Text] [Related]
4. Choroidal metastasis in a patient with disseminated breast cancer: hormonal therapy-induced regression.
El-Saify WM
Breast J; 2006; 12(5):490-2. PubMed ID: 16958973
[No Abstract] [Full Text] [Related]
5. The use of early adjuvant aromatase inhibitor therapy: contributions from the BIG 1-98 letrozole trial.
Forbes JF
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S2-7. PubMed ID: 16730270
[TBL] [Abstract][Full Text] [Related]
6. Hormonal therapies for early breast cancer: systematic review and economic evaluation.
Hind D; Ward S; De Nigris E; Simpson E; Carroll C; Wyld L
Health Technol Assess; 2007 Jul; 11(26):iii-iv, ix-xi, 1-134. PubMed ID: 17610808
[TBL] [Abstract][Full Text] [Related]
7. Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial.
Goss PE
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S8-12. PubMed ID: 16730271
[TBL] [Abstract][Full Text] [Related]
8. Choroidal and optic disc metastases from breast cancer and their response to combination pharmacotherapy with tamoxifen, cyclophosphamide hydrate, letrozole, and bevacizumab.
Zako M; Takeyama M; Naito E; Mizumoto K; Iwaki M
J Ocul Pharmacol Ther; 2012 Feb; 28(1):89-93. PubMed ID: 22011078
[TBL] [Abstract][Full Text] [Related]
9. Bilateral choroidal metastases as the initial presentation of breast carcinoma.
O'Gorman CS; Awad ZT; Given HF
Ir Med J; 2001 Mar; 94(3):85-6. PubMed ID: 11354691
[TBL] [Abstract][Full Text] [Related]
10. Letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen.
Mann BS; Johnson JR; Kelly R; Sridhara R; Williams G; Pazdur R
Clin Cancer Res; 2005 Aug; 11(16):5671-7. PubMed ID: 16115902
[TBL] [Abstract][Full Text] [Related]
11. Update of the BIG 1-98 Trial: where do we stand?
Joerger M; Thürlimann B
Breast; 2009 Oct; 18 Suppl 3():S78-82. PubMed ID: 19914548
[TBL] [Abstract][Full Text] [Related]
12. Letrozole improves disease-free survival vs tamoxifen in adjuvant treatment of early breast cancer.
Oncology (Williston Park); 2005 Mar; 19(3):277, 360. PubMed ID: 15828547
[No Abstract] [Full Text] [Related]
13. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.
Goss PE; Ingle JN; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Tu D; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Pater JL
J Natl Cancer Inst; 2005 Sep; 97(17):1262-71. PubMed ID: 16145047
[TBL] [Abstract][Full Text] [Related]
14. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
[TBL] [Abstract][Full Text] [Related]
15. [Advanced breast cancer in a patient achieving long-term SD after letrozole administration for liver metastasis developing during anastrozole therapy].
Ichinose Y; Kobayashi T; Fujimoto A; Uchida S; Sasaoki T; Goto K
Gan To Kagaku Ryoho; 2010 Dec; 37(13):2913-6. PubMed ID: 21160269
[TBL] [Abstract][Full Text] [Related]
16. Extending the benefits of adjuvant therapy in early HR+ breast cancer.
Goss PE
Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():45-52. PubMed ID: 18785006
[TBL] [Abstract][Full Text] [Related]
17. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
Jahanzeb M
Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
[TBL] [Abstract][Full Text] [Related]
18. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
[TBL] [Abstract][Full Text] [Related]
19. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
; Thürlimann B; Keshaviah A; Coates AS; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Rabaglio M; Smith I; Wardley A; Price KN; Goldhirsch A
N Engl J Med; 2005 Dec; 353(26):2747-57. PubMed ID: 16382061
[TBL] [Abstract][Full Text] [Related]
20. A decade of letrozole: FACE.
O'Shaughnessy J
Breast Cancer Res Treat; 2007; 105 Suppl 1(Suppl 1):67-74. PubMed ID: 17912637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
